Meds Apotek AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,006	829.23	655.2	609	193.09
Revenue Growth (YoY)	21.37%	26.56%	7.59%	215.40%	-15.86%
Cost of Revenue	778.45	640.73	534.23	455.55	148.21
Gross Profit	227.94	188.5	120.97	153.45	44.88
Selling, General & Admin	221.79	183.89	154	72.98	25.54
Other Operating Expenses	-11.63	-7.99	-4.39	171.58	60.2
Operating Expenses	230.35	196.65	170.24	260.01	89.01
Operating Income	-2.41	-8.16	-49.28	-106.57	-44.13
Interest Expense	-1.03	-3.91	-3.81	-1.17	-0.35
Interest & Investment Income	0.43	0.95	1.44	-	-
Currency Exchange Gain (Loss)	-	-	0.16	-	-
Other Non Operating Income (Expenses)	-0	-	0	-	-
Pretax Income	-3	-11.11	-51.48	-107.74	-44.47
Income Tax Expense	-10.73	-0.71	-0.46	1.77	0.34
Earnings From Continuing Operations	7.73	-10.4	-51.02	-109.51	-44.81
Net Income to Company	7.73	-10.4	-51.02	-109.51	-44.81
Net Income	7.73	-10.4	-51.02	-109.51	-44.81
Net Income to Common	7.73	-10.4	-51.02	-	-
Shares Outstanding (Basic)	18	17	17	-	-
Shares Outstanding (Diluted)	18	17	17	-	-
Shares Change (YoY)	3.40%	2.98%	-	-	-
EPS (Basic)	0.44	-0.60	-3.05	-	-
EPS (Diluted)	0.43	-0.60	-3.05	-	-
Free Cash Flow	-21.83	19.84	-49.78	-	-
Free Cash Flow Per Share	-1.22	1.15	-2.97	-	-
Gross Margin	22.65%	22.73%	18.46%	25.20%	23.24%
Operating Margin	-0.24%	-0.98%	-7.52%	-17.50%	-22.85%
Profit Margin	0.77%	-1.25%	-7.79%	-	-
Free Cash Flow Margin	-2.17%	2.39%	-7.60%	-	-
EBITDA	-0.28	-5.96	-46.94	-91.11	-40.86
EBITDA Margin	-0.03%	-0.72%	-7.16%	-14.96%	-21.16%
D&A For EBITDA	2.12	2.19	2.33	-	-
EBIT	-2.41	-8.16	-49.28	-106.57	-44.13
EBIT Margin	-0.24%	-0.98%	-7.52%	-17.50%	-22.85%
Revenue as Reported	1,018	837.39	659.97	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.